CO5261530A1 - Cristales de derivado de acido oxiiminoalcanoico - Google Patents

Cristales de derivado de acido oxiiminoalcanoico

Info

Publication number
CO5261530A1
CO5261530A1 CO00081698A CO00081698A CO5261530A1 CO 5261530 A1 CO5261530 A1 CO 5261530A1 CO 00081698 A CO00081698 A CO 00081698A CO 00081698 A CO00081698 A CO 00081698A CO 5261530 A1 CO5261530 A1 CO 5261530A1
Authority
CO
Colombia
Prior art keywords
oxiiminoalcanoic
acid derivative
derivative crystals
crystals
oxazolylmethoxy
Prior art date
Application number
CO00081698A
Other languages
English (en)
Inventor
Yu Momose
Imoto Hiroshi
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CO5261530A1 publication Critical patent/CO5261530A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cristales de ácido (E)4-[4-(5-metil-2-fenil-4-oxazolilmetoxi)benziloxiimino]-4-fenilbutírico (Con la condición de que los cristales que tengan un punto de fusión de 126°C a 127°C queden excluidos).
CO00081698A 1999-10-29 2000-10-26 Cristales de derivado de acido oxiiminoalcanoico CO5261530A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30834699 1999-10-29

Publications (1)

Publication Number Publication Date
CO5261530A1 true CO5261530A1 (es) 2003-03-31

Family

ID=17979966

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00081698A CO5261530A1 (es) 1999-10-29 2000-10-26 Cristales de derivado de acido oxiiminoalcanoico

Country Status (19)

Country Link
US (1) US6777435B1 (es)
EP (1) EP1224178B1 (es)
KR (1) KR100433885B1 (es)
CN (1) CN1407975A (es)
AR (1) AR031078A1 (es)
AT (1) ATE243684T1 (es)
AU (1) AU7958100A (es)
CA (1) CA2388200A1 (es)
CL (1) CL2000002938A1 (es)
CO (1) CO5261530A1 (es)
DE (1) DE60003577T2 (es)
HK (1) HK1044536A1 (es)
HU (1) HUP0203884A3 (es)
MY (1) MY135840A (es)
NO (1) NO20022007L (es)
PE (1) PE20010761A1 (es)
PL (1) PL364171A1 (es)
TW (1) TW558554B (es)
WO (1) WO2001032637A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030134884A1 (en) * 2000-03-28 2003-07-17 Masatoshi Hazama Neovascularization inhibitors
US6838442B2 (en) * 2001-04-04 2005-01-04 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
ATE423559T1 (de) 2001-04-04 2009-03-15 Ortho Mcneil Janssen Pharm Kombinationstherapie durch glukoseresorptionshemmer und ppar modulatoren
EP1400529A4 (en) * 2001-05-30 2007-12-19 Kissei Pharmaceutical GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF
TWI327462B (en) * 2002-01-18 2010-07-21 Sumitomo Chemical Co Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
US7556926B2 (en) 2002-05-24 2009-07-07 Takeda Pharmaceuticals Company Ltd. Methods for screening insulin-sensitizing agents
WO2006036686A2 (en) * 2004-09-24 2006-04-06 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
EP1937297A2 (en) * 2005-09-08 2008-07-02 Gastrotech Pharma A/S Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort
TW201138843A (en) 2009-12-18 2011-11-16 Colgate Palmolive Co Biguanide preservation of precipitated calcium carbonate
CA2937107C (en) * 2014-01-17 2020-12-22 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
KR102281228B1 (ko) 2019-09-03 2021-07-22 신창수 과수나무의 가지지지용 파이프클램프

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058510A1 (en) 1998-05-11 1999-11-18 Takeda Chemical Industries, Ltd. Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
AU7958000A (en) * 1999-10-29 2001-05-14 Takeda Chemical Industries Ltd. Process for the preparation of oxyiminoalkanoic acid derivatives

Also Published As

Publication number Publication date
HK1044536A1 (en) 2002-10-25
KR100433885B1 (ko) 2004-06-04
DE60003577T2 (de) 2004-04-29
MY135840A (en) 2008-07-31
US6777435B1 (en) 2004-08-17
CN1407975A (zh) 2003-04-02
EP1224178A1 (en) 2002-07-24
EP1224178B1 (en) 2003-06-25
PL364171A1 (en) 2004-12-13
HUP0203884A3 (en) 2005-01-28
WO2001032637A1 (en) 2001-05-10
HUP0203884A2 (hu) 2003-03-28
AU7958100A (en) 2001-05-14
CA2388200A1 (en) 2001-05-21
PE20010761A1 (es) 2001-08-01
TW558554B (en) 2003-10-21
CL2000002938A1 (es) 2009-05-15
NO20022007D0 (no) 2002-04-26
AR031078A1 (es) 2003-09-10
NO20022007L (no) 2002-06-24
KR20010102429A (ko) 2001-11-15
DE60003577D1 (de) 2003-07-31
ATE243684T1 (de) 2003-07-15

Similar Documents

Publication Publication Date Title
CO5261530A1 (es) Cristales de derivado de acido oxiiminoalcanoico
PT1193270E (pt) Pirrolobenzodiazepinas
ATE88183T1 (de) Substituierte 4-(chinolin-2-yl-methoxy)phenylessigs|ure-derivate.
FI935842A0 (fi) Anvaendning av tetrahydrokarbazonderivat som 5HT1 -reseptoragonister
DK0629616T3 (da) Optisk aktive 2-imidazolin-5-on-derivater som fungicider
NO943383D0 (no) Substituerte pipekolinsyre-derivater som HIV-proteaseinhibitorer
EA200000683A1 (ru) Производные ряда 4-(2-кето-1-бензимидазолинил)пиперидина в качестве агонистов orl1-рецептора
FI924311A0 (fi) Nya 2-substituerade indan-2 -merkaptoacetylamidderivat anvaendbara som inhibitorer av enkefalinas och ace.
DK0863891T3 (da) (Methylsulfonyl)phenyl-2-(5H)-furanoner som COX2-inhibitorer
NO20054581L (no) Substituerte 1-oksoisoindoliner og deres anvendelse i farmasoytiske preparater for a redusere inflammatoriske cykotinnivaer
DK0481522T3 (da) Nye mercaptoacetylamid-derivater anvendelige som inhibitorer af enkephalinase og ACE
DK0449216T3 (da) 3,5-Di-tertiærbutyl-4-hydroxyphenylmethylenderivater af 2-substituerede thiazolidinoner, oxazolidinoner og imidazolidinoner som antiinflammatoriske midler
EA200201057A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
UY26454A1 (es) Cristal de 4-carboxamino-1,2,3,4-tetrahidroquinolina 2-sustituida
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
PT918759E (pt) Novos derivados de tiazolidino-2,4-diona substituidos processos para a sua obtencao e as composicoes farmaceuticas que os contem
DE69935873D1 (de) 2-Methyl-thieno-benzodiazepin Formulierung
DE69231593D1 (de) Rüttelfreies dreibein-doppelgelenk
PT1233953E (pt) Novos derivados de benzotiadiazinas processo para a sua preparacao e as composicoes farmaceuticas que os contem
FI955498A0 (fi) Nipekotiinihappojohdannaisia hyytymistä estävinä aineina
NO892746L (no) Buntspenneledd av store lengder for spennbetong med paafoelgende forbinding saavel som fremgangsmaate for dennes innbygging.
DE69715173T2 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
EA199800675A1 (ru) Дифенилстильбены как пролекарства к ингибиторам циклооксигеназы(сох-2)
DK0888340T3 (da) 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin
IS4079A (is) Milliefni til framleiðslu á súbstitúeruðum bensimidasólum

Legal Events

Date Code Title Description
FC Application refused